Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1129-1135
Published online before print May 16, 2002, doi: 10.1161/01.ATV.0000022600.61391.A5
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
22/7/1129    most recent
01.ATV.0000022600.61391.A5v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Bahr, S.
Right arrow Articles by Björkhem, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Bahr, S.
Right arrow Articles by Björkhem, I.
Related Collections
Right arrow Cell biology/structural biology
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1129.)
© 2002 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Mechanism of Accumulation of Cholesterol and Cholestanol in Tendons and the Role of Sterol 27-hydroxylase (CYP27A1)

Sara von Bahr; Tomas Movin; Nikos Papadogiannakis; Irina Pikuleva; Per Rönnow; Ulf Diczfalusy; Ingemar Björkhem

From the Divisions of Clinical Chemistry (S.v.B., U.D., I.B.), Orthopedics (T.M.), Pathology (N.P.), and Lung Medicine (P.R.), Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden; and Department of Pharmacology and Toxicology (I.P.), University of Texas Medical Branch, Galvestone, Tex.

Correspondence to Ingemar Björkhem, Division of Clinical Chemistry, Karolinska Institutet, Huddinge University Hospital, SE-141 86 Stockholm. E-mail Ingemar.Bjorkhem{at}chemlab.hs.sll.se

Objective Tendon xanthomas are deposits of lipids and connective tissue commonly found in hypercholesterolemic patients. Macrophages are likely to be responsible for the lipid accumulation. Normolipidemic patients with the rare disease cerebrotendinous xanthomatosis, lacking the enzyme sterol 27-hydroxylase (CYP27A1), develop prominent xanthomas in tendons and brain containing both cholestanol and cholesterol, with a cholestanol:cholesterol ratio higher than that in the circulation. Because of its ability to convert cholesterol into polar metabolites that leave the cells faster, CYP27A1 has been suggested to be an antiatherogenic enzyme. The hypothesis was tested that tendons contain CYP27A1 that may be of importance for the normal efflux of both steroids.

Methods and Results Western blotting and combined gas chromatography-mass spectrometry showed that human tendons contain significant amounts of CYP27A1 and its product, 27-hydroxycholesterol. Immunohistochemistry showed that CYP27A1 is present in macrophages and tenocytes. The tendons also contained cholestanol, with a cholestanol:cholesterol ratio slightly higher than that in the circulation. Recombinant human CYP27A1, and cultured human macrophages containing this enzyme, had similar activity toward cholesterol and cholestanol. After loading of macrophages with labeled cholesterol and cholestanol, there was an efflux of these steroids in both unmetabolized and 27-oxygenated form, resulting in a significant cellular accumulation of cholestanol compared with cholesterol.

Conclusion The results are consistent with the possibility that CYP27A1 is of importance for the efflux of both cholesterol and cholestanol from tendons.


Key Words: tendon xanthomas • cerebrotendinous xanthomatosis • atherosclerosis • sterol transport




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
U. Panzenboeck, U. Andersson, M. Hansson, W. Sattler, S. Meaney, and I. Bjorkhem
On the mechanism of cerebral accumulation of cholestanol in patients with cerebrotendinous xanthomatosis
J. Lipid Res., May 1, 2007; 48(5): 1167 - 1174.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. Escher, A. Hoang, S. Georges, U. Tchoua, A. El-Osta, Z. Krozowski, and D. Sviridov
Demethylation using the epigenetic modifier, 5-azacytidine, increases the efficiency of transient transfection of macrophages
J. Lipid Res., February 1, 2005; 46(2): 356 - 365.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Norlin, S. von Bahr, I. Bjorkhem, and K. Wikvall
On the substrate specificity of human CYP27A1: implications for bile acid and cholestanol formation
J. Lipid Res., August 1, 2003; 44(8): 1515 - 1522.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Escher, Z. Krozowski, K. D. Croft, and D. Sviridov
Expression of Sterol 27-Hydroxylase (CYP27A1) Enhances Cholesterol Efflux
J. Biol. Chem., March 21, 2003; 278(13): 11015 - 11019.
[Abstract] [Full Text] [PDF]